TCF7L2 has shown associations with angiographically determined CHD in diabetic and non-diabetic patients [31], as well as with CVD, ischemic stroke, peripheral artery disease, and all-cause mortality [32]. This evidence concerns the gene TCF7L2 and ischemic stroke.